1 |
Chen Q, Nan Y, Yang Y, Xiao Z, Liu M, Huang J, Xiang Y, Long X, Zhao T, Wang X, Huang Q, Ai K. Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney. Bioactive Materials 2023;22:141-167. [DOI: 10.1016/j.bioactmat.2022.09.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
2 |
Chen Q, Wang X, Yuan C, Nan Y, Huang Q, Ai K. 2D-nanomaterials for AKI treatment. Front Bioeng Biotechnol 2023;11. [DOI: 10.3389/fbioe.2023.1159989] [Reference Citation Analysis]
|
3 |
Zhu Y, Liu Y, Khan K, Arkin G, Tareen AK, Xie Z, He T, Su L, Guo F, Lai X, Xu J, Zhang J. Ultrasound combined with nanomaterials for cancer therapy. Materials Today Advances 2023;17:100330. [DOI: 10.1016/j.mtadv.2022.100330] [Reference Citation Analysis]
|
4 |
Liu Z, Han Z, Jin X, An J, Kim J, Chen W, Kim JS, Zheng J, Deng J. Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19. Acta Pharm Sin B 2023. [PMID: 36846153 DOI: 10.1016/j.apsb.2023.02.010] [Reference Citation Analysis]
|
5 |
Wang S, Chen Q, Zhao T, Ai K, Hu C. Nanomedicine-based treatment: An emerging therapeutical strategy for pulmonary hypertension. Nano Res 2023. [DOI: 10.1007/s12274-022-5310-6] [Reference Citation Analysis]
|
6 |
Huang Q, Yang Y, Zhu Y, Chen Q, Zhao T, Xiao Z, Wang M, Song X, Jiang Y, Yang Y, Zhang J, Xiao Y, Nan Y, Wu W, Ai K. Oral Metal-Free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD). Small 2023;:e2207350. [PMID: 36760016 DOI: 10.1002/smll.202207350] [Reference Citation Analysis]
|
7 |
Shen C, Yue X, Dai L, Wang J, Li J, Fang Q, Zhi Y, Shi C, Li W. Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer. J Cancer Res Clin Oncol 2023;149:683-99. [PMID: 36436092 DOI: 10.1007/s00432-022-04385-4] [Reference Citation Analysis]
|
8 |
Xu W, Ci L, Qi M, Xiao G, Chen X, Xu W, Lu Y. Sr2+-dependent microstructure regulation of biodegradable Sr-doped hydroxyapatite microspheres with interconnected porosity for sustained drug delivery. Ceramics International 2023. [DOI: 10.1016/j.ceramint.2023.02.077] [Reference Citation Analysis]
|
9 |
Wang M, Liang Y, Liao F, Younis MR, Zheng Y, Zhao X, Yu X, Guo W, Zhang DY. Iridium Tungstate Nanozyme-Mediated Hypoxic Regulation and Anti-inflammation for Duplex Imaging Guided Photothermal Therapy of Metastatic Breast Tumors. ACS Appl Mater Interfaces 2022;14:56471-82. [PMID: 36519432 DOI: 10.1021/acsami.2c14799] [Reference Citation Analysis]
|
10 |
Zhong S, Yao S, Zhao Q, Wang Z, Liu Z, Li L, Wang ZL. Electricity‐Assisted Cancer Therapy: From Traditional Clinic Applications to Emerging Methods Integrated with Nanotechnologies. Advanced NanoBiomed Research 2022. [DOI: 10.1002/anbr.202200143] [Reference Citation Analysis]
|
11 |
Wang R, Shi J, Zhang Q, Peng Q, Sun X, Song L, Zhang Y. Dual-Triggered Near-Infrared Persistent Luminescence Nanoprobe for Autofluorescence-Free Imaging-Guided Precise Therapy of Rheumatoid Arthritis. Adv Sci (Weinh) 2023;10:e2205320. [PMID: 36461720 DOI: 10.1002/advs.202205320] [Reference Citation Analysis]
|
12 |
Fu Q, Yu L, Wang Y, Li P, Song J. Biomarker‐Responsive Nanosystems for Chronic Disease Theranostics. Adv Funct Materials 2022. [DOI: 10.1002/adfm.202206300] [Reference Citation Analysis]
|
13 |
Chen J, Zeng S, Xue Q, Hong Y, Liu L, Song L, Fang C, Zhang H, Wang B, Sedgwick AC, Zhang P, Sessler JL, Liu C, Chen J. Photoacoustic image-guided biomimetic nanoparticles targeting rheumatoid arthritis. Proc Natl Acad Sci U S A 2022;119:e2213373119. [PMID: 36256822 DOI: 10.1073/pnas.2213373119] [Reference Citation Analysis]
|
14 |
Chen L, Zhao T, Liu M, Chen Q, Yang Y, Zhang J, Wang S, Zhu X, Zhang H, Huang Q, Ai K. Ultra-small molybdenum-based nanodots as an antioxidant platform for effective treatment of periodontal disease. Front Bioeng Biotechnol 2022;10:1042010. [DOI: 10.3389/fbioe.2022.1042010] [Reference Citation Analysis]
|
15 |
Yang Y, Liu M, Zhao T, Chen Q, Yang Y, Wang S, Zhang J, Deng G, Sun K, Nan Y, Cao K, Ai K, Huang Q. Epigallocatechin-3-gallate Mo nanoparticles (EGM NPs) efficiently treat liver injury by strongly reducing oxidative stress, inflammation and endoplasmic reticulum stress. Front Pharmacol 2022;13:1039558. [DOI: 10.3389/fphar.2022.1039558] [Reference Citation Analysis]
|
16 |
Chen W, Cheng H, Xia W. Progress in the Surface Functionalization of Selenium Nanoparticles and Their Potential Application in Cancer Therapy. Antioxidants (Basel) 2022;11:1965. [PMID: 36290687 DOI: 10.3390/antiox11101965] [Reference Citation Analysis]
|
17 |
Huang Q, Lyu M, Tang W, Qi P, Hu H. Hydrogel co-loading SO2 prodrug and FeGA nanoparticles for enhancing chemodynamic therapy by photothermal-triggered SO2 gas therapy. Front Bioeng Biotechnol 2022;10:1024089. [DOI: 10.3389/fbioe.2022.1024089] [Reference Citation Analysis]
|
18 |
Jia T, Li D, Du J, Fang X, Gerasimov V, Ågren H, Chen G. A bimodal type of AgPd Plasmonic Blackbody Nanozyme with boosted catalytic efficacy and synergized photothermal therapy for efficacious tumor treatment in the second biological window. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01627-y] [Reference Citation Analysis]
|
19 |
Tang W, Li X, Liu Z, Meng L, Zhu D, Huang Q. CuS nanoparticles and camptothecin co-loaded thermosensitive injectable hydrogel with self-supplied H2O2 for enhanced chemodynamic therapy. Front Bioeng Biotechnol 2022;10:1003777. [DOI: 10.3389/fbioe.2022.1003777] [Reference Citation Analysis]
|
20 |
Yang Y, Zhao T, Chen Q, Li Y, Xiao Z, Xiang Y, Wang B, Qiu Y, Tu S, Jiang Y, Nan Y, Huang Q, Ai K. Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC. Advanced Science. [DOI: 10.1002/advs.202202797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
21 |
Cui F, Liu J, Pang S, Li B. Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform. Front Pharmacol 2022;13:929854. [DOI: 10.3389/fphar.2022.929854] [Reference Citation Analysis]
|
22 |
Xiang Y, Liu M, Yang Y, Wang Y, Qiu Y, Tu S, Jiang Y, Nan Y, Zhang X, Huang Q. Nanodrugs Manipulating Endoplasmic Reticulum Stress for Highly Effective Antitumor Therapy. Front Pharmacol 2022;13:949001. [DOI: 10.3389/fphar.2022.949001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
23 |
Shi X, Tian Y, Liu Y, Xiong Z, Zhai S, Chu S, Gao F. Research Progress of Photothermal Nanomaterials in Multimodal Tumor Therapy. Front Oncol 2022;12:939365. [DOI: 10.3389/fonc.2022.939365] [Reference Citation Analysis]
|
24 |
Xiao Z, Chen Q, Yang Y, Tu S, Wang B, Qiu Y, Jiang Y, Huang Q, Ai K. State of the Art Advancements in Sonodynamic Therapy (SDT): Metal-Organic Frameworks for SDT. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.137889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
25 |
Zhu S, Wang S, Liu C, Lyu M, Huang Q. Cu-Hemin Nanosheets and Indocyanine Green Co-Loaded Hydrogel for Photothermal Therapy and Amplified Photodynamic Therapy. Front Oncol 2022;12:918416. [DOI: 10.3389/fonc.2022.918416] [Reference Citation Analysis]
|
26 |
Chen H, Hou K, Yu J, Wang L, Chen X. Nanoparticle-Based Combination Therapy for Melanoma. Front Oncol 2022;12:928797. [DOI: 10.3389/fonc.2022.928797] [Reference Citation Analysis]
|
27 |
Jin L, Yang C, Wang J, Li J, Xu N. Recent Advances in Nanotheranostic Agents for Tumor Microenvironment–Responsive Magnetic Resonance Imaging. Front Pharmacol 2022;13:924131. [DOI: 10.3389/fphar.2022.924131] [Reference Citation Analysis]
|
28 |
Zhou C, Chen X, Huang Y, Zhang Q, Zhu S, Fu W. Nanomaterial Technology and Soft Tissue Sarcomas. Front Oncol 2022;12:921983. [DOI: 10.3389/fonc.2022.921983] [Reference Citation Analysis]
|
29 |
Fu W, Li T, Chen H, Zhu S, Zhou C. Research Progress in Exosome-Based Nanoscale Drug Carriers in Tumor Therapies. Front Oncol 2022;12:919279. [DOI: 10.3389/fonc.2022.919279] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
30 |
Xiang Y, Li N, Liu M, Chen Q, Long X, Yang Y, Xiao Z, Huang J, Wang X, Yang Y, Zhang J, Liu C, Huang Q. Nanodrugs Detonate Lysosome Bombs. Front Pharmacol 2022;13:909504. [PMID: 35656308 DOI: 10.3389/fphar.2022.909504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
31 |
Long X, Zhang X, Chen Q, Liu M, Xiang Y, Yang Y, Xiao Z, Huang J, Wang X, Liu C, Nan Y, Huang Q. Nucleus-Targeting Phototherapy Nanodrugs for High-Effective Anti-Cancer Treatment. Front Pharmacol 2022;13:905375. [PMID: 35645841 DOI: 10.3389/fphar.2022.905375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
32 |
Lin Y, Yi O, Hu M, Hu S, Su Z, Liao J, Wang W, Wang S, Liu L, Liu B, Cai X. Multifunctional nanoparticles of sinomenine hydrochloride for treat-to-target therapy of rheumatoid arthritis via modulation of proinflammatory cytokines. J Control Release 2022;348:42-56. [PMID: 35569587 DOI: 10.1016/j.jconrel.2022.05.016] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
33 |
Xu S, Chang L, Zhao X, Hu Y, Lin Y, Chen Z, Ren X, Mei X. Preparation of epigallocatechin gallate decorated Au-Ag nano-heterostructures as NIR-sensitive nano-enzymes for the treatment of osteoarthritis through mitochondrial repair and cartilage protection. Acta Biomater 2022;144:168-82. [PMID: 35358735 DOI: 10.1016/j.actbio.2022.03.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
34 |
Huang J, Huang Q, Liu M, Chen Q, Ai K. Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy. Front Pharmacol 2022;13:844037. [DOI: 10.3389/fphar.2022.844037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
|